Moms on arthritis drug help science understand breastfeeding safety
NCT ID NCT06888193
Summary
This study aims to measure how much of the medication bimekizumab (Bimzelx®) passes into breast milk. It will enroll 20 breastfeeding mothers who are already using this drug to treat conditions like psoriasis or arthritis. Researchers will collect breast milk samples over several weeks to understand the amount of medication an infant might receive.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Up0122 102
RECRUITINGDurham, North Carolina, 27710, United States
-
Up0122 103
RECRUITINGSouth Miami, Florida, 33155, United States
-
Up0122 105
RECRUITINGSanta Monica, California, 90404, United States
-
Up0122 201
RECRUITINGVancouver, Canada
-
Up0122 202
RECRUITINGCalgary, Canada
-
Up0122 303
RECRUITINGHerne, Germany
-
Up0122 501
RECRUITINGBarcelona, Spain
-
Up0122 502
RECRUITINGBarcelona, Spain
-
Up0122 601
RECRUITINGSankt Gallen, Switzerland
-
Up0122 602
RECRUITINGLausanne, Switzerland
Conditions
Explore the condition pages connected to this study.